Catalyst Crew Technologies Corp. (OTC: CCTC) announced today that it has submitted a corporate action request to the Financial Industry Regulatory Authority (FINRA) seeking approval to change its corporate name to LataMed AI Corp. and its trading symbol. The proposed changes aim to align the company's public identity with its strategic transition toward artificial intelligence-enabled healthcare technology, with an initial focus on Latin America.
The corporate action, approved by the board of directors and the majority shareholder, does not involve any reverse stock split, forward stock split, recapitalization, or change to authorized capital. The company's issued and outstanding share count will remain unchanged, and existing shareholders will not need to take any action. Upon FINRA approval, the company will file a Certificate of Amendment with the Nevada Secretary of State to effect the name change.
Dr. Kevin Rodan Levy, CEO of Catalyst Crew Technologies Corp., stated, "There is no change to the Company’s capital structure as part of this process. This proposed name change is intended to better align the Company’s public identity with its healthcare technology strategy and long-term market focus."
The company is transitioning from its previous operations to focus on AI-driven digital health solutions for emerging markets. Its strategy includes developing telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms. The company aims to address the growing demand for modernized healthcare delivery systems, particularly in Latin America.
No assurance can be given that FINRA will approve the proposed name change or the timing of any such approval. For more information, visit https://catalystcrewai.com or review the company's filings with the SEC at www.sec.gov.
The company is a development-stage enterprise and has not generated revenues from its newly announced business direction. There can be no assurance that it will successfully implement its business plan, complete acquisitions, secure financing, or obtain regulatory approvals. Investors should carefully review all risk factors and disclosures in the company's SEC filings before making any investment decisions.
